A role for the cyclin box in the ubiquitin-mediated degradation of cyclin G1

被引:17
作者
Piscopo, Denise M. [1 ]
Hinds, Philip W. [1 ]
机构
[1] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA
关键词
D O I
10.1158/0008-5472.CAN-07-6346
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclin G1 was identified as a transcriptional target of p53 that encodes a protein with strong homology to the cyclin family of cell cycle regulators. We show that either ectopically expressed or endogenous cyclin G1 protein is very unstable, undergoes modification with ubiquitin, and is likely degraded by the proteasome. Ectopic cyclin G1 protein stability is increased by cyclin box mutation or by association with inactive cyclin-dependent kinase (CDK) subunits, suggesting that a function of cyclin G1 as a CDK regulator may be required for its rapid turnover. Furthermore, cyclin G1 and the cyclin box mutant interact with and are ubiquitinated by MDM2, another transcriptional target of p53 that acts as a negative regulator of p53 stability. These data suggest that the cyclin box has a role in the proteasome-mediated degradation of cyclin G1 and thus suggest a putative rote for a CDK in cyclin G1 metabolism and function.
引用
收藏
页码:5581 / 5590
页数:10
相关论文
共 50 条
[21]   Reduced hepatic tumor incidence in cyclin G1-deficient mice [J].
Jensen, MR ;
Factor, VM ;
Fantozzi, A ;
Helin, K ;
Huh, CG ;
Thorgeirsson, SS .
HEPATOLOGY, 2003, 37 (04) :862-870
[22]   GAK: A cyclin G associated kinase contains a tensin/auxilin-like domain [J].
Kanaoka, Y ;
Kimura, SH ;
Okazaki, I ;
Ikeda, M ;
Nojima, H .
FEBS LETTERS, 1997, 402 (01) :73-80
[23]  
Kang CM, 2003, RADIAT RES, V159, P312, DOI 10.1667/0033-7587(2003)159[0312:PBFIRE]2.0.CO
[24]  
2
[25]   Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein [J].
Kimura, SH ;
Nojima, H .
GENES TO CELLS, 2002, 7 (08) :869-880
[26]   Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery [J].
Kimura, SH ;
Ikawa, M ;
Ito, A ;
Okabe, M ;
Nojima, H .
ONCOGENE, 2001, 20 (25) :3290-3300
[27]  
Kubbutat MHG, 1999, CELL GROWTH DIFFER, V10, P87
[28]   Mono-versus polyubiquitination: Differential control of p53 fate by Mdm2 [J].
Li, MY ;
Brooks, CL ;
Wu-Baer, F ;
Chen, DL ;
Baer, R ;
Gu, W .
SCIENCE, 2003, 302 (5652) :1972-1975
[29]   THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION [J].
MOMAND, J ;
ZAMBETTI, GP ;
OLSON, DC ;
GEORGE, D ;
LEVINE, AJ .
CELL, 1992, 69 (07) :1237-1245
[30]   Recycling the cell cycle: Cyclins revisited [J].
Murray, AW .
CELL, 2004, 116 (02) :221-234